An experimental vaccine against Alzheimer鈥檚 disease has cleared its first
hurdle. Elan Pharmaceuticals of Dublin announced this week that the first 100
patients to receive the vaccine had not suffered any serious side effects. Some
showed an immune response. Codenamed AN-1792, the vaccine is a synthetic version
of the amyloid protein that clogs up the brains of patients. The company now
plans to test the vaccine in the US and Europe.
More from New 女生小视频
Explore the latest news, articles and features
Mind
Adults may be more creative than children 鈥� but less confident about it
News
Technology
Global race to update computers as AI discovers most disruptive hack yet
News
Technology
People are vibe coding copyrighted apps with AI 鈥� will tech firms sue?
Comment
Health
Cholesterol may disrupt the brain’s cleaning system in Alzheimer’s disease
News
Popular articles
Trending New 女生小视频 articles